Stock Taper
Adagio Medical Holdings, Inc. develops and commercializes cryoablation devices for treating cardiac arrhythmias like atrial fibrillation, flutter, and ventricular tachycardia.

The vCLAS™ Cryoablation System, FDA Breakthrough Device, uses proprietary Ultra-Low Temperature Cryoablation to create durable lesions for treating ventricular tachycardia and is in pivotal U.S. clinical trials.
Overall rating: C
| PEER | PRICE | |
|---|---|---|
COCH | $0.69 | COMPARE |
IRIX | $0.71 | COMPARE |
CTXR | $0.60 | COMPARE |
VVOS | $0.22 | COMPARE |
CODX | $1.21 | COMPARE |
VSEE | $0.02 | COMPARE |
NVNO | $10.75 | COMPARE |